Ameregen is an investment portfolio of post-launch and late stage bio-engineering, nano-tech, and stem cell therapies.
Current main focus of my daily work is in international high-finance/structured finance/VC/SPV/Hedge Funds & banks. The Ameregen Group has exclusive access to assets that are valued at $29 billion (international accounting) in cancer specialty therapeutics manufacturing, sales, marketing and distribution rights for key (non-US minded) nations, in SPVs. Monetizing these assets with exclusive launch partners in state-of-the-art advanced cancer care hospitals is current.
Ameregen is a Venture Philanthropy Corporation. "Doing good while doing good business" is our motto. Presently Ameregen is involved building a state-of-the-art advanced cancer-rescue division at a leading university hospital where patients can self-select not to receive chemotherapies and seek cures via cell therapies as Center of Cancer Excellence.
Successful serial entrepreneur in the emergent stem cell pharmaceuticals industry. Specialties: launch team building, ultra-high-performance life science, personalized medicine, adv. cancer-rescues, intl. high-finance/structured finance, automated cGMP manufacturing of cellular therapeutics with economies of scale, high-tech/high-growth management, disruptive cancer therapeutics: R&D, immune proteomics, cellular cancer immunity, bench-to-bedside, clinic systems.
Supporting Media/TV/Health/Cancer-Help Channels, Public Speaker, Public Awareness - Domain Expert on Stem Cells.
What I love about Ameregen are the people and the cutting edge, state of the art adult stem cell industry. I strongly believe in our field. Occasionally, I make myself available as Board Member to help other stem cell companies thrive.
I lead by excellence, encouragement, and example solving challenges by win-win state-of-the-art solutions that are typically "out-of-the-box", team and patient centered, and cross-disciplinary approaches. Important to me to stay true to who I am and what I believe - please note that I believe in treating cancer without chemotherapies as there is no data that shows actual cancer cures outside of childhood cancer, blood cancer, and testicular cancer as it relates to the use of chemotherapies - since introduction of the cruel and expensive chemotherapies in the 1950s. Instead, I have seen our fully approved CITA cell therapies acutely and completely destroy advanced stage IV, multi-drug-resistant cancers in as little as 4 hours, and cure patients permanently, without side effects. Even multi-drug-resistant (MDR+) advanced and stage IV cancer patients who were declared "as good as dead" before receiving life-saving CITA cell therapy in our facilities 10 years ago were completely cured to a full and fully functional life, and still remain cured cancer-free. Thus, my mission in life is the 2020 roll-out of the Eradicate Cancer 2020 Project, and we love partnering with pioneering philanthropists, and leaders of industry, society and state-of-the-art medicine. "Doing good while doing good business": Ameregen contributes the much needed CITA cancer rescue technology that is faster, cheaper, better & side-effect free.